Lusutrombopag

FDA Drug Profile — Mulpleta

Drug Details

Generic Name
Lusutrombopag
Brand Names
Mulpleta
Application Number
NDA210923
Sponsor
VANCOCIN ITALIA SRL
NDC Codes
4
Dosage Forms
TABLET, FILM COATED, POWDER
Routes
ORAL
Active Ingredients
LUSUTROMBOPAG

Indications and Usage

1 INDICATIONS AND USAGE MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. ( 1 )